SG Americas Securities’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$156K Sell
2,600
-111,900
-98% -$39.9M ﹤0.01% 2753
2025
Q4
$1.74M Buy
+114,500
New +$36.3M ﹤0.01% 1617
2025
Q1
Sell
-177,400
Closed -$48K 3452
2024
Q4
$48K Buy
177,400
+68,500
+63% +$20.3M ﹤0.01% 2911
2024
Q3
$331K Sell
108,900
-21,600
-17% -$7.07M ﹤0.01% 2053
2024
Q2
$1.98M Sell
130,500
-6,700
-5% -$1.97M 0.01% 956
2024
Q1
$3.29M Sell
137,200
-263,700
-66% -$77.2M 0.02% 691
2023
Q4
$9.95M Buy
400,900
+367,100
+1,086% +$100M 0.09% 207
2023
Q3
$974K Sell
33,800
-150,000
-82% -$37.4M 0.01% 1284
2023
Q2
$1.94M Sell
183,800
-11,400
-6% -$2.65M 0.01% 755
2023
Q1
$2.1M Buy
195,200
+36,200
+23% +$8.89M 0.02% 633
2022
Q4
$578K Sell
159,000
-377,500
-70% -$101M 0.01% 1411
2022
Q3
$715K Buy
536,500
+217,500
+68% +$52.7M 0.01% 1239
2022
Q2
$687K Buy
319,000
+219,000
+219% +$53.7M 0.01% 1665
2022
Q1
$505K Buy
+100,000
New +$23M ﹤0.01% 1879
2020
Q4
Sell
-24,500
Closed -$47K 3317
2020
Q3
$47K Buy
+24,500
New +$6.07M ﹤0.01% 2526
2020
Q2
Sell
-30,000
Closed -$39K 3671
2020
Q1
$39K Sell
30,000
-192,400
-87% -$42M ﹤0.01% 3214
2019
Q4
$2.32M Buy
222,400
+190,000
+586% +$41.9M 0.02% 740
2019
Q3
$118K Hold
32,400
﹤0.01% 2645
2019
Q2
$102K Sell
32,400
-55,000
-63% -$9.85M ﹤0.01% 2804
2019
Q1
$270K Sell
87,400
-159,600
-65% -$30.5M ﹤0.01% 2348
2018
Q4
$1.03M Buy
247,000
+50,000
+25% +$9.75M 0.01% 1301
2018
Q3
$2.13M Buy
197,000
+50,000
+34% +$9.85M 0.02% 1121
2018
Q2
$793K Sell
147,000
-158,000
-52% -$27.9M 0.01% 1656
2018
Q1
$882K Sell
305,000
-187,800
-38% -$34.5M 0.01% 1444
2017
Q4
$2.4M Sell
492,800
-19,200
-4% -$3.4M 0.02% 759
2017
Q3
$5.47M Buy
512,000
+276,600
+118% +$49M 0.05% 292
2017
Q2
$2.24M Buy
235,400
+94,900
+68% +$15.4M 0.02% 819
2017
Q1
$1.25M Sell
140,500
-158,600
-53% -$26.4M 0.01% 1217
2016
Q4
$524K Buy
299,100
+49,900
+20% +$7.51M ﹤0.01% 1664
2016
Q3
$1.08M Buy
249,200
+50,000
+25% +$8.46M 0.01% 1111
2016
Q2
$600K Buy
199,200
+52,200
+36% +$8.12M ﹤0.01% 1603
2016
Q1
$700K Sell
147,000
-106,900
-42% -$15.9M 0.01% 1547
2015
Q4
$1.93M Buy
+253,900
New +$39.9M 0.01% 728
2015
Q3
Sell
-198,800
Closed -$1.15M 2070
2015
Q2
$1.15M Buy
198,800
+60,600
+44% +$9.71M 0.01% 1005
2015
Q1
$1.28M Buy
138,200
+73,800
+115% +$11.6M 0.01% 1004
2014
Q4
$1.27M Buy
64,400
+12,200
+23% +$1.9M 0.01% 1138
2014
Q3
$661K Buy
52,200
+24,300
+87% +$3.17M ﹤0.01% 1340
2014
Q2
$161K Buy
+27,900
New +$3.23M ﹤0.01% 2147
2014
Q1
Sell
-24,400
Closed -$339K 2407
2013
Q4
$339K Sell
24,400
-23,200
-49% -$2.64M ﹤0.01% 1765
2013
Q3
$1.02M Sell
47,600
-11,200
-19% -$1.21M ﹤0.01% 1255
2013
Q2
$625K Buy
+58,800
New +$6.1M ﹤0.01% 1156

Other funds holding AMGN

SG Americas Securities's AMGN Position: Q1 2026 in Review

SG Americas Securities increased its Amgen (AMGN) stake by 11% in Q1 2026, buying an estimated $16.2M and bringing the position to 442,661 shares worth $156M. The position accounts for 0.17% of the portfolio, ranked #99.

SG Americas Securities first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • SG Americas Securities held 442,661 shares of Amgen worth $156M as of Q1 2026.
  • SG Americas Securities bought 45,442 Amgen shares in Q1 2026, an estimated $16.2M.
  • Amgen made up 0.17% of SG Americas Securities's portfolio in Q1 2026, its #99 holding.
  • SG Americas Securities first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.